Advances in Animal and Veterinary Sciences

Research Article
Adv. Anim. Vet. Sci. 9(10): 1684-1691
 
Figure 1

Edema diameter in arthritis, EPO and EVOO treated rats. 

Figure 2

Total leucocytic count in arthritis, EPO and EVOO treated rats. 

Figure 3

Platelets count in arthritis, EPO and EVOO treated rats. 

Figure 4

Serum RF levels in arthritis, EPO and EVOO treated rats. 

Figure 5

Serum TNF-α levels in arthritis, EPO and EVOO treated rats. 

Figure 6

Serum IL-1β levels in arthritis, EPO and EVOO treated rats. 

Figure 7

Serum IL-6 levels in arthritis, EPO and EVOO treated rats. 

Figure 8

Ankles of rats 10 dpi by (H and E x 100). A: No histopathological changes in the control (normal) group; B: inflammatory cells (IC) infiltration and focal necrosis (FN) of articular cartilage in arthritis group; C: Few inflammatory cell infiltrations in the EPO-treated group; D: Few inflammatory cell infiltrations in EVOO-treated group. 

Figure 9

Ankles of rat 21 dpi showing: by (H and E x 100). A: No histopathological changes in the control (normal) group; B: inflammatory cells (IC) infiltration and focal necrosis (FN) of articular cartilage in arthritis group; C: Few inflammatory cell infiltrations (H and E) in the EPO-treated group; D: Few inflammatory cell infiltrations (H and E) in EVOO-treated group. 

Figure 10

Spleen of rat 10 dpi showing by (H and E x 100). A: No histopathological changes in the control (normal) group; B: lymphoblasts proliferation and mitotic figure in arthritis group; C: inflammatory cells infiltration in EPO treated group; D: inflammatory cells infiltration in EVOO treated group. 

Figure 11

Spleen of rat 21 dpi by (H and E x 100) showing. A: No histopathological changes in the control (normal) group; B: lymphoblasts proliferation and mitotic figure in arthritis group; C: No histopathological changes in the EPO-treated group; D: No histopathological changes in the EVOO-treated group.